CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Reconciliation of net income to cash provided by operating activities:
Net income	$ 57,122	$ 7,374
Add (deduct):
Depreciation and amortization	6,430	4,231
Provision for bad debt	708	154
Net realized and unrealized (gains) losses	(3,274)	11,091
Amortization of net premium on debt securities investments	938	1,144
Payments for title losses less than (in excess of) provisions	12,234	(2,809)
Adjustments for insurance recoveries of title losses	(205)	173
(Increase) decrease in receivables – net	(3,513)	11,542
Increase in other assets – net	(7,869)	(3,813)
Decrease in accounts payable and other liabilities – net	(20,116)	(43,165)
Change in net deferred income taxes	2,007	1,495
Net income from equity method investments	(924)	(645)
Dividends received from equity method investments	764	1,235
Stock-based compensation expense	3,174	887
Other – net	(34)	(254)
Cash provided (used) by operating activities	47,442	(11,360)
Investing activities:
Proceeds from sales of investments in securities	3,051	11,796
Proceeds from matured investments in debt securities	42,836	18,814
Purchases of investments in securities	(47,881)	(30,703)
Net sales (purchases) of short-term investments	2,648	2,982
Purchases of property and equipment, and real estate – net	(5,721)	(4,781)
Cash paid for acquisition of businesses	(52,575)	(1,449)
Cash paid for acquisition of equity method investment	(16,080)	0
Other – net	131	38
Cash used by investing activities	(73,591)	(3,303)
Financing activities:
Proceeds from notes payable	178,975	204
Payments on notes payable	(154,910)	(8,223)
Distributions to noncontrolling interests	(3,844)	(3,326)
Repurchases of Common Stock	(1,935)	(393)
Cash dividends paid	(8,840)	(7,099)
Distributions to noncontrolling interests	(2,570)	0
Other - net	(777)	0
Cash provided (used) by financing activities	6,160	(18,837)
Effects of changes in foreign currency exchange rates	69	(3,510)
Change in cash and cash equivalents	(19,920)	(37,010)
Cash and cash equivalents at beginning of period	432,683	330,609
Cash and cash equivalents at end of period	412,763	293,599
Proceeds from Stock Options Exercised	$ 61	$ 0